An experimental pain medicine met the primary goal of a late-stage clinical trial, the drugmaker said Tuesday, setting the stage for it to seek approval from the US Food and Drug Administration this year and potentially providing an alternative to opioids tha…
Comments
（ ﾟДﾟ）
There's nothing here…